Monday, June 22, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 562 of 1,261
  1. US 9994585

    Transplantation therapies

    Aphios Corporation · Granted Jun 12, 2018 · Expires Jun 7, 2038

    granted
  2. US 9987347

    Vaccines against multiple subtypes of dengue virus

    Inovio Pharmaceuticals, Inc. · Granted Jun 5, 2018 · Expires May 31, 2038

    granted
  3. US 9988630

    Methods and compositions for the specific inhibition of gene expression by double-stranded RNA

    INTEGRATED DNA TECHNOLOGIES, INC. · Granted Jun 5, 2018 · Expires May 31, 2038

    granted
  4. US 9987324

    Traditional chinese medicine composition and the use thereof

    INFINITUS (CHINA) COMPANY LTD. · Granted Jun 5, 2018 · Expires May 31, 2038

    granted
  5. US 9988397

    ERK inhibitors

    MSD R&D (China) Co. Ltd. · Granted Jun 5, 2018 · Expires May 31, 2038

    granted
  6. US 9987253

    Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes

    Jenrin Discovery, LLC · Granted Jun 5, 2018 · Expires May 31, 2038

    granted
  7. US 9987233

    Injectable sustained release composition and method of using the same for treating inflammation in joints and pain associated therewith

    Eupraxia Pharmaceuticals USA LLC · Granted Jun 5, 2018 · Expires May 31, 2038

    granted
  8. US 9987377

    Targeted gene delivery to non-phagocytic mammalian cells via bacterially derived intact minicells

    EnGeneIC Molecular Delivery Pty Ltd · Granted Jun 5, 2018 · Expires May 31, 2038

    granted
  9. US 9987330

    Methods of treating or preventing pruritis by blocking natriuretic polypeptide B

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 5, 2018 · Expires May 31, 2038

    granted
  10. US 9986724

    Genetically modified non-human animals and methods of use thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Jun 5, 2018 · Expires May 31, 2038

    granted
  11. US 9988602

    Methods for producing enucleated erythroid cells derived from pluripotent stem cells

    Astellas Institute for Regenerative Medicine · Granted Jun 5, 2018 · Expires May 31, 2038

    granted
  12. US 9987284

    Substituted benzooxadiazole DNA-PK inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Jun 5, 2018 · Expires May 31, 2038

    granted
  13. US 9988603

    Large scale generation of functional megakaryocytes and platelets from human embryonic stem cells under stromal-free conditions

    Stem Cell & Regenerative Medicine International · Granted Jun 5, 2018 · Expires May 31, 2038

    granted
  14. US 9988447

    Treatment of diabetes

    XBIOTECH INC. · Granted Jun 5, 2018 · Expires May 31, 2038

    granted
  15. US 9987500

    Human antibodies to PD-1

    REGENERON PHARMACEUTICALS, INC. · Granted Jun 5, 2018 · Expires May 31, 2038

    granted
  16. US 9988382

    [9,10-dimethoxy-3-(2-methylpropyl)-1H,2H,3H,4H,6H,7H,11bH-pyrido-[2,1-A]isoquinolin-2-yl]methanol and compounds, compositions and methods relating thereto

    Neurocrine Biosciences, Inc. · Granted Jun 5, 2018 · Expires May 31, 2038

    granted
  17. US 9988371

    Benzimidazole analogues and related methods

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Jun 5, 2018 · Expires May 31, 2038

    granted
  18. US 9988334

    Salts of treprostinil

    United Therapeutics Corporation · Granted Jun 5, 2018 · Expires May 31, 2038

    granted
  19. US 9988394

    Oxabicycloheptane prodrugs

    Lixte Biotechnology, Inc. · Granted Jun 5, 2018 · Expires May 31, 2038

    granted
  20. US 9987350

    Antigens and vaccines directed against human enteroviruses

    SENTINEXT THERAPEUTICS Sdn Bhd · Granted Jun 5, 2018 · Expires May 31, 2038

    granted
  21. US 9987363

    Materials with water-triggered drug-release properties for localized therapeutics

    The Board of Regents of the University of Texas System · Granted Jun 5, 2018 · Expires May 31, 2038

    granted
  22. US 9987346

    Methods and compositions for vaccinating a subject for a sexually transmitted pathogen

    The Regents of the University of California · Granted Jun 5, 2018 · Expires May 31, 2038

    granted
  23. US 9987326

    Klotho protein and related compounds for the treatment and diagnosis of cancer

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Jun 5, 2018 · Expires May 31, 2038

    granted
  24. US 9987261

    Substituted diazaspiroalkanes as androgen receptor modulators

    The Regents of the University of California · Granted Jun 5, 2018 · Expires May 31, 2038

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.